David N. Everly

1.2k total citations
18 papers, 1.0k citations indexed

About

David N. Everly is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, David N. Everly has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in David N. Everly's work include Viral-associated cancers and disorders (9 papers), Herpesvirus Infections and Treatments (6 papers) and Histiocytic Disorders and Treatments (4 papers). David N. Everly is often cited by papers focused on Viral-associated cancers and disorders (9 papers), Herpesvirus Infections and Treatments (6 papers) and Histiocytic Disorders and Treatments (4 papers). David N. Everly collaborates with scholars based in United States and Japan. David N. Everly's co-authors include G. Sullivan Read, Nancy Raab‐Traub, Pinghui Feng, Bernardo A. Mainou, Shahzad I. Mian, Vivek Vikram Singh, Chikoti Leela, Dipanjan Dutta, Bala Chandran and Jie Lu and has published in prestigious journals such as Oncogene, Journal of Virology and Virology.

In The Last Decade

David N. Everly

18 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David N. Everly United States 14 482 388 364 335 132 18 1.0k
Sumita Bhaduri‐McIntosh United States 21 374 0.8× 488 1.3× 625 1.7× 384 1.1× 175 1.3× 51 1.2k
Daphne van Leeuwen Netherlands 18 691 1.4× 233 0.6× 849 2.3× 797 2.4× 190 1.4× 20 1.5k
Natalie Sutkowski United States 13 209 0.4× 269 0.7× 211 0.6× 322 1.0× 70 0.5× 23 853
Barbora Lubyová Czechia 14 427 0.9× 252 0.6× 541 1.5× 607 1.8× 77 0.6× 22 1.1k
Merrill J. Kellum United States 12 298 0.6× 270 0.7× 656 1.8× 839 2.5× 59 0.4× 14 1.2k
Marie-Claude Trescol-Biémont France 14 366 0.8× 146 0.4× 218 0.6× 384 1.1× 77 0.6× 20 805
Margaret K. Offermann United States 21 527 1.1× 318 0.8× 643 1.8× 569 1.7× 165 1.3× 34 1.4k
Pramod P. Naranatt United States 11 861 1.8× 232 0.6× 978 2.7× 308 0.9× 176 1.3× 14 1.4k
Liudmila Matskova Sweden 19 118 0.2× 510 1.3× 284 0.8× 188 0.6× 94 0.7× 42 954
Vivek Vikram Singh United States 10 339 0.7× 366 0.9× 285 0.8× 414 1.2× 56 0.4× 10 793

Countries citing papers authored by David N. Everly

Since Specialization
Citations

This map shows the geographic impact of David N. Everly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Everly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Everly more than expected).

Fields of papers citing papers by David N. Everly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Everly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Everly. The network helps show where David N. Everly may publish in the future.

Co-authorship network of co-authors of David N. Everly

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Everly. A scholar is included among the top collaborators of David N. Everly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Everly. David N. Everly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ramachandran, Akshaya, Binod Kumar, Gulam Waris, & David N. Everly. (2021). Deubiquitination and Activation of the NLRP3 Inflammasome by UCHL5 in HCV-Infected Cells. Microbiology Spectrum. 9(1). e0075521–e0075521. 26 indexed citations
2.
Lefaiver, Cheryl, et al.. (2016). The effects of human milk fortification on nutrients and milk properties. Journal of Perinatology. 37(1). 42–48. 25 indexed citations
3.
Everly, David N., et al.. (2015). Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins. Journal of Virology. 89(14). 7277–7290. 12 indexed citations
4.
Ansari, Mairaj Ahmed, Vivek Vikram Singh, Sujoy Dutta, et al.. (2013). Constitutive Interferon-Inducible Protein 16-Inflammasome Activation during Epstein-Barr Virus Latency I, II, and III in B and Epithelial Cells. Journal of Virology. 87(15). 8606–8623. 163 indexed citations
5.
6.
7.
Everly, David N., Bernardo A. Mainou, & Nancy Raab‐Traub. (2009). Transcriptional Downregulation of p27KIP1 through Regulation of E2F Function during LMP1-Mediated Transformation. Journal of Virology. 83(24). 12671–12679. 11 indexed citations
8.
Everly, David N., Bernardo A. Mainou, & Nancy Raab‐Traub. (2008). The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation. Virology. 376(2). 258–269. 13 indexed citations
9.
Mainou, Bernardo A., David N. Everly, & Nancy Raab‐Traub. (2007). Unique Signaling Properties of CTAR1 in LMP1-Mediated Transformation. Journal of Virology. 81(18). 9680–9692. 64 indexed citations
10.
Mainou, Bernardo A., David N. Everly, & Nancy Raab‐Traub. (2005). Epstein–Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene. 24(46). 6917–6924. 113 indexed citations
11.
Feng, Pinghui, David N. Everly, & G. Sullivan Read. (2005). mRNA Decay during Herpes Simplex Virus (HSV) Infections: Protein-Protein Interactions Involving the HSV Virion Host Shutoff Protein and Translation Factors eIF4H and eIF4A. Journal of Virology. 79(15). 9651–9664. 99 indexed citations
12.
Everly, David N., Shuichi Kusano, & Nancy Raab‐Traub. (2004). Accumulation of Cytoplasmic β-Catenin and Nuclear Glycogen Synthase Kinase 3β in Epstein-Barr Virus-Infected Cells. Journal of Virology. 78(21). 11648–11655. 48 indexed citations
13.
Everly, David N., Bernardo A. Mainou, & Nancy Raab‐Traub. (2004). Induction of Id1 and Id3 by Latent Membrane Protein 1 of Epstein-Barr Virus and Regulation of p27/Kip and Cyclin-Dependent Kinase 2 in Rodent Fibroblast Transformation. Journal of Virology. 78(24). 13470–13478. 73 indexed citations
14.
Everly, David N., Pinghui Feng, Shahzad I. Mian, & G. Sullivan Read. (2002). mRNA Degradation by the Virion Host Shutoff (Vhs) Protein of Herpes Simplex Virus: Genetic and Biochemical Evidence that Vhs Is a Nuclease. Journal of Virology. 76(17). 8560–8571. 138 indexed citations
15.
Feng, Pinghui, David N. Everly, & G. Sullivan Read. (2001). mRNA Decay during Herpesvirus Infections: Interaction between a Putative Viral Nuclease and a Cellular Translation Factor. Journal of Virology. 75(21). 10272–10280. 86 indexed citations
16.
17.
Everly, David N. & G. Sullivan Read. (1997). Mutational analysis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): characterization of HSV type 1 (HSV-1)/HSV-2 chimeras. Journal of Virology. 71(10). 7157–7166. 46 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumita Bhaduri‐McIntosh Breakdown of academic impact, for papers by Daphne van Leeuwen Breakdown of academic impact, for papers by Natalie Sutkowski Breakdown of academic impact, for papers by Barbora Lubyová Breakdown of academic impact, for papers by Merrill J. Kellum Breakdown of academic impact, for papers by Marie-Claude Trescol-Biémont Breakdown of academic impact, for papers by Margaret K. Offermann Breakdown of academic impact, for papers by Pramod P. Naranatt Breakdown of academic impact, for papers by Liudmila Matskova Breakdown of academic impact, for papers by Vivek Vikram Singh
Rankless by CCL
2026